# RevealDx

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/revealdx

- Industry: Software
- Headquarters: Seattle, US
- Website: www.mindsharemed.com/
- Total disclosed funding: $2M
- Latest round: Seed (May 6, 2014)
- Investors on record: 1

## About

Founded in 2014 and based in Seattle, US, RevealDx specializes in clinical decision support technology, enhancing diagnostic accuracy and treatment effectiveness for healthcare providers across various settings.RevealDx, established in 2014 in Seattle, US, focuses on developing advanced clinical decision support tools. The company was founded by Samir Chowdhury, who has a background in healthcare technology. RevealDx has executed 3 funding deals, with the latest round in July 2024 raising USD 3.63 mn, bringing the total capital raised to USD 3.63 mn.RevealDx offers a personalized diagnostic platform that uses evidence-based methodologies to provide clinicians with tailored guidance on follow-up procedures and treatments. Their solutions are aimed at addressing missed diagnoses and false positives, improving disease detection and characterization. The company serves a diverse clientele, including integrated delivery networks (IDNs), accountable care organizations (ACOs), and clinics under risk-based contracts, primarily within urban healthcare providers in the US.RevealDx generates revenue through a subscription-based model, delivering clinical decision support solutions to healthcare organizations. Their clients, which include hospitals, clinics, and health systems, subscribe to access the platform for their medical specialists. The company’s pricing structure reflects the value offered through real-time analytics and personalized diagnostics, ensuring their services integrate smoothly into existing healthcare workflows.In July 2024, RevealDx raised USD 3.63 mn in venture funding, which will be utilized to further enhance their product offerings and expand into new markets. The company is focused on designing additional features for their diagnostic platform and plans to target urban healthcare markets across the US for expansion by the end of 2025.

## Funding rounds

- Seed, May 6, 2014, $2M — Frost Data Capital

## Investors

- Frost Data Capital (https://capitalatlas.ai/funds/frost-data-capital) — Seed